| Sandoz Pharmaceuticals AG - Pemetrexed Sandoz conc. 500 mg/20 ml, Konzentrat zur Herstellung einer Infusionslösung |
| 66501 | | 02 | | Pemetrexed Sandoz conc. 500 mg/20 ml | | Konzentrat zur Herstellung einer Infusionslösung | | L01BA04 | | Pemetrexed | | 17.07.2018 | | |
|
| Composition |
| pemetrexedum 500.0 mg ut pemetrexedum dinatricum hemipentahydricum 604.2 mg, natrii thiosulfas, propylenglycolum 1000.0 mg, acidum hydrochloridum, natrii hydroxidum, nitrogenium, aqua ad iniectabile q.s. ad solutionem pro 20 ml corresp. natrium 56.7 mg. |
| Packungsbestandteile |
| Concentrate for infusion | | | | | | | | Active Agent | Dose |
|---|
| Pemetrexed | 500mg / 20ml |
| | BAG: Active Agent | Dose |
|---|
| Pemetrexed | 500 mg |
| | | | Inactive agents | Dose |
|---|
| Acidum Hydrochloridum | | | Sodium Hydroxide | | | Sodium Thiosulfate | | | Nitrogenium | | | Propylenglycol | 1000mg / 20ml |
| |
|
|
